Table 3.
Patient | Contour | JI | MDC (mm) | VD (%) | DSC | SI | II | TS |
---|---|---|---|---|---|---|---|---|
P1 | L2 | 0.44 (0.16) | 8.70 (4.18) | −39.64 (16.46) | 0.61 (0.17) | 0.49 (0.17) | 0.83 (0.19) | 1.8 |
L3 | 0.42 (0.16) | 10.03 (10.43) | −23.23 (44.11) | 0.59 (0.22) | 0.54 (0.21) | 0.69 (0.26) | 1.5 | |
L4 | 0.52 (0.12) | 7.39 (1.97) | −25.63 (15.63) | 0.70 (0.10) | 0.61 (0.13) | 0.83 (0.10) | 2.8 | |
p-value | 0.164 | 0.500 | 0.087 | 0.194 | 0.268 | 0.076 | ||
OOO | ||||||||
AVE | 0.457 | 8.706 | −29.499 | 0.632 | 0.548 | 0.785 | ||
P2 | L2 | 0.40 (0.12) | 9.05 (2.70) | −32.33 (20.18) | 0.60 (0.12) | 0.51 (0.14) | 0.76 (0.12) | 1.3 |
L3 | 0.43 (0.13) | 8.64 (6.09) | −13.33 (41.50) | 0.64 (0.14) | 0.60 (0.17) | 0.74 (0.16) | 2.2 | |
L4 | 0.49 (0.08) | 7.78 (1.76) | −32.66 (15.40) | 0.67 (0.07) | 0.57 (0.11) | 0.85 (0.07) | 2.5 | |
p-value | 0.125 | 0.135 | 0.231 | 0.209 | 0.200 | 0.014 | ||
OOO | L4 | |||||||
AVE | 0.439 | 8.493 | −26.107 | 0.635 | 0.557 | 0.782 | ||
P3 | L2 | 0.28 (0.13) | 12.22 (5.80) | 38.21 (53.41) | 0.45 (0.18) | 0.54 (0.24) | 0.40 (0.16) | 1.2 |
L3 | 0.35 (0.19) | 11.80 (12.08) | 44.03 (95.12) | 0.51 (0.25) | 0.57 (0.26) | 0.51 (0.29) | 1.8 | |
L4 | 0.53 (0.13) | 8.28 (4.23) | −18.04 (22.90) | 0.70 (0.12) | 0.63 (0.13) | 0.80 (0.16) | 3.0 | |
p-value | <0.001 | 0.042 | 0.001 | 0.001 | 0.796 | <0.001 | ||
OOO | L4 | L2a | L4 | L4 | L4 | |||
AVE | 0.383 | 10.768 | 21.402 | 0.550 | 0.580 | 0.570 |
AVE, average; DSC, DICE similarity coefficient; II, inclusion index; JI, Jaccard index; MDC, mean distance to conformity; OOO, odd-one-out (the one differing from the others in the group); P1, P2, P3, patient 1, 2 and 3; SI, sensitivity index; TS, total score; VD, volume difference.
Standard deviations (SDs) are put in parentheses.
Statistically significant p-values (<0.05) are highlighted in bold.
p-values 0.07 and 0.01 towards L3 and L4, respectively.